The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...
Alkermes' experimental drug significantly improved wakefulness and reduced excessive daytime sleepiness in patients with a rare sleep disorder in a mid-stage study, it said on Wednesday. Shares of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback